June 4, 2019 | Lao Tribune

Daily Archives June 4, 2019

Vricon and Cesium partner to bring users streaming 3D geodata

Vricon and Cesium roll out free trials of 3D data at GEOINT 2019 Symposium McLean, Virginia, June 04, 2019 (GLOBE NEWSWIRE) — Vricon, a producer of geospatial 3D solutions, and Cesium—a complete platform for building time-dynamic, 3D geospatial applications—are disrupting the geospatial industry by providing accurate 3D geodata in the cloud and making it accessible […]Read More

World’s top miners keep performing but investors unimpressed

Revenue up 8% to $683 billion EBITDA up 4% to $165 billion Record dividend paid to shareholders of $43 billion, up 13% Market capitalisation of the Top 40 down 18% to $757 billion, 31 Dec 2018 with partial recovery to $849 bn at 30 Apr 2019 LONDON, June 04, 2019 (GLOBE NEWSWIRE) — The world’s […]Read More

Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease ...

Toronto, Canada, June 04, 2019 (GLOBE NEWSWIRE) –Vielight Inc. of Toronto, a leader in brain photobiomodulation (PBM) technology, announces that the primary site for its pivotal clinical trial, St. Michael’s Hospital, in Toronto, has been activated. The trial will be a randomized, placebo-controlled study involving 228 subjects with moderate to severe cognitive impairment due to […]Read More

Cocoon Medical Appoints Miguel Pardos as Chief Executive Officer

Barcelona, Spain, May. 27, 2019 – Cocoon Medical (“Cocoon”), a leading developer and provider of energy-based aesthetic systems for practitioners worldwide, today announced the appointment of Miguel Pardos as its Chief Executive Officer (“CEO”), effective immediately. Immediately prior to joining Cocoon, Mr. Pardos served as the Vice President Aesthetic APAC at Lumenis based in Hong […]Read More


NANOBIOTIX APPOINTS NEW CHIEF MEDICAL OFFICER AS THE COMPANY EVOLVES AFTER ACHIEVEMENT OF EUROPEAN MARKET APPROVAL Biopharmaceutical veteran Edwina Baskin-Bey, M.D., joins Nanobiotix as its new Chief Medical Officer (CMO) Dr. Baskin-Bey will leverage her expertise in medical strategy and late-stage clinical development to help accelerate the company’s strategic objectives Dr. Baskin-Bey succeeds Elsa Borghi, […]Read More